High Dose Cytarabine and Clofarabine (HiDAC→CLOF) in Relapsed or Refractory Acute Myeloid Leukemia, a Phase 2 Trial.

被引：0
|
作者：
Powell, Bayard [1 ]
D'Agostino, Ralph, Jr. [1 ]
Levitan, Denise [1 ]
Ellis, Leslie Renee [1 ]
Lyerly, Susan [1 ]
Skiles, Megan [1 ]
Manuel, Megan [1 ]
Harrelson, Robin [1 ]
Kimbrough, Claire [1 ]
Hurd, David Duane [1 ]
机构：
[1] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：676 / 676
页数：1
相关论文
共 50 条
  • [21] The Use of Clofarabine and Cytarabine Combination (CLARA) As Salvage Therapy for Relapsed and/or Refractory Acute Myeloid Leukemia (AML)
    Leung, Anskar Y. H.
    Tse, Eric
    Liu, Herman S. Y.
    Sim, Joycelyn
    Kho, Bonnie C. S.
    Yip, Sze-Fai
    Lee, Harold K. K.
    Kwong, Yok Lam
    [J]. BLOOD, 2012, 120 (21)
  • [22] CLOFARABINE, CYTARABINE AND MITOXANTRONE FOR RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA - INTERIM RESULTS OF A PROSPECTIVE PHASE 2 STUDY
    Gill, H.
    Ip, H. W.
    Yip, S. F.
    Kho, B.
    Lee, H.
    Mak, V.
    Lau, J.
    Lau, C. K.
    Lin, S. Y.
    Wong, R.
    Li, W.
    Kwong, Y. L.
    [J]. HAEMATOLOGICA, 2017, 102 : 677 - 677
  • [23] A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemia
    Griffiths, Elizabeth A.
    Brady, William E.
    Tan, Wei
    Vigil, Carlos E.
    Thompson, James E.
    Ford, Laurie A.
    Dickey, Noelle M.
    Bashaw, Heather L.
    Sperrazza, Jill
    Wetzler, Meir
    Wang, Eunice S.
    [J]. LEUKEMIA RESEARCH, 2016, 43 : 44 - 48
  • [24] Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients
    Scappini, Barbara
    Gianfaldoni, Giacomo
    Caracciolo, Francesco
    Mannelli, Francesco
    Biagiotti, Caterina
    Romani, Claudio
    Pogliani, Enrico M.
    Simonetti, Federico
    Borin, Lorenza
    Fanci, Rosa
    Cutini, Ilaria
    Longo, Giovanni
    Susini, Maria Chiara
    Angelucci, Emanuele
    Bosi, Alberto
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (12) : 1047 - 1051
  • [25] A dose escalation and phase II study of gemtuzumab ozogamicin (GO) with high-dose cytarabine (HiDAC) for patients (Pts) with refractory or relapsed acute myeloid leukemia (AML): CALGB 19902.
    Stone, RM
    Moser, B
    Schulman, P
    Barrier, RC
    Kolitz, JE
    Allen, SL
    Stock, W
    Galinsky, IA
    Khoury, H
    Larson, RA
    [J]. BLOOD, 2004, 104 (11) : 249A - 249A
  • [26] A PHASE I TRIAL OF LENALIDOMIDE IN COMBINATION WITH INTERMEDIATE DOSE CYTARABINE (IDC) IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (AML) PATIENTS
    Vigil, E.
    Griffiths, A.
    Thompson, E.
    Brady, E.
    Dickey, M.
    Ford, A.
    Wang, S.
    Wetzler, M.
    [J]. HAEMATOLOGICA, 2012, 97 : 33 - 33
  • [27] Phase II Study of the Combination of Clofarabine Plus Idarubicin and Cytarabine (CIA) In Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
    Naqvi, Kiran
    Ravandi, Farhad
    Kantarjian, Hagop
    Borthakur, Gautam
    Ferrajoli, Alessandra
    Thomas, Deborah A.
    Koller, Charles Asa
    Konopleva, Marina
    Byrd, Anna
    Kwari, Monica
    Faderl, Stefan
    [J]. BLOOD, 2010, 116 (21) : 464 - 465
  • [28] A phase I trial of liposomal daunorubicin (Daunoxome®) administered with high-dose cytarabine (HiDAC) to patients (pts) with relapsed acute leukemia (AL).
    Cripe, L
    Kneebone, P
    Roberts, L
    Mukwaya, G
    Rutledge, C
    Gordon, M
    [J]. BLOOD, 1998, 92 (10) : 233A - 233A
  • [29] A Phase I Study of Lenalidomide and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
    Griffiths, Elizabeth A.
    Brady, William
    Tan, Wei
    Vigil, Carlos E.
    Thompson, James E.
    Ford, Laurie A.
    Dickey, Noelle M.
    Sperrazza, Jill
    Wang, Eunice S.
    Wetzler, Meir
    [J]. BLOOD, 2014, 124 (21)
  • [30] Southwest Oncology Group Study S0530: A Phase 2 Trial of Clofarabine/ Cytarabine for Relapsed Refractory Acute Lymphocytic Leukemia
    Advani, Anjali
    Gundacker, Holly
    Sala-Torra, Olga
    Radich, Jerald
    Lai, Raymond
    Slovak, Marilyn L.
    Lancet, Jeffrey E.
    Coutre, Steve
    Stuart, Robert K.
    Mims, Martha P.
    Stiff, Patrick
    Appelbaum, Frederick R.
    [J]. BLOOD, 2009, 114 (22) : 1203 - 1203
12345